Three JAK Inhibitors Get Boxed Warnings, Modified Indications ...Middle East

Medscape - News
The FDA is limiting all approved uses of tofacitinib, baricitinib, and upadacitinib to patients who have not responded well to TNF blockers, to ensure their benefits outweigh their risks. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Three JAK Inhibitors Get Boxed Warnings, Modified Indications )

Also on site :